| Lightcalls.com |
|
|
![]() |
upon my place in Montana, I attempt...upon my place in Montana, I attempt to grow many of the botanicals about which I write. We've got hawthorn, gingko, senior mullein, lavender, sage, thyme, echinacea, borage, yarrow and adequate supply of pine trees. But united plant I don't try to wax is Piper methysticum, the increasingly well-known kava kava. Kava is a tropical low tree native to the Pacific Island region, a climate distinctly different from the American Northern Rockies where I live. Kava is a member of the pepper family, Piperaceae, a plant clump that contains over 1,000 species, including the familiar culinary spice, black pepper The kava plant enlarges as tall as 20 feet in rich, fertile soil, however it is more often lay the foundation of at a height of 6 feet Its leaves are bright recent heart shaped, and themselves put forth up to 8 inches in fulness The stems are succulent, and have dark flourishing to black distended nodes. However, it is the cause of the kava plant which is held in high prize and the focus of novel botanical interest. What's in kava? Kava origin contains a group of amalgamates known as lactones, or more specifically "kava-lactones." Kava lactones are similar in chemical arrangement to a compound known as myristicin - raise in nutmeg. At this point in time, 15 lactones have been isolated from kava. As a collection lactones make up between 3 to 20 percent of the kava root Of particular interest are four mixs known as kavain, dihydrokavain, methysticin and dihydromethystin. According to researchers, these lactones have significant pain-reducing properties. Historic beverage The geographic region known as the Pacific Islands includes as it is places as Melanesia, Papua of the present day Guinea, the Solomon Islands and Vanuatu. In those areas, indigenous population have been using kava for thousands of years. Traditional use ranges from the formal to the informal, occasions to honor royalty and private gatherings of family and friends. Kava was and is traded and exchanged as gifts, with the greatest in number potent and special kava reserv for special human frames The prime age for the greatest in number prized kava root is four to six years. The indigenous mode of consuming kava is as an infusion made by way of chewing the root until it is mashed into a pulp-like substance, then placing the masticated kava in devoid of warmth [i]or[/i] heat water and steeping it until a powerful tea forms. The infusion is then serv in chalices or bowls, sometimes strained, and sometimes serv with the mashed etymon still mixed in. Certain kava users bring forward the latter since drinking the tea and simultaneously chewing cause remnants results in an level more potent kava effect. new Use While for thousands of years, kava has been used as a ceremonial and social herb, its recent use is as an anxiolytic, or anti-anxiety, agent. Natural relief for anxiety Anxiety is common of today's most common psychiatric conditions. It events almost 1 in 20 adults, two-thirds of whom are women In addition to feelings of terror, overwhelming dread and looming catastrophe, those suffering with anxiety can also experience unpleasant, equable frightening physical symptoms: heart palpitations, chill sweats, dizziness and nausea. Insomnia is another usual problem for anxious people. In many cases, anxiety can be crippling. Repetitious, chronic anxiety can debilitate its sufferer marring friendships, work at jobs opportunities and family relationships. A category of mix with drugss known as benzodiazepines (Xanax, Valium and Halcion are examples of these drugs) are principally commonly used in the treatment of anxiety. While these medicines do work to temporarily peduncle anxiety, the adverse effects of benzodiazepines are well known, and fairly significant. They include memory impairment, sedation and concatenation For this reason, effective, non-toxic alternatives to mix with drugs therapy for anxiety are eagerly sought by dint of both patients and their healthcare providers. A variety of studies upon the use of kava kava in the treatment of anxiety indicate that it is an effective alternative to certain prescription medications. A review and meta-analysis of the efficacy of kava for the treatment of anxiety was published in the February 2000 issue of the Journal of Clinical Psychopharmacology. The authors, working subordinate to the auspices of the Department of Complementary Medicine, seminary of Postgraduate Medicine and Health Sciences at the University of Exeter Exeter United Kingdom, did extensive literature searches and confered with a variety of person specially versed s on kava. These researchers contemplateed at 14 studies on kava, then narrowed their review to 7 of the 14 studies which met their stringent criteria for quality and reliability. According to these researchers, the "superiority of kava extract through placebo was suggested by all seven reviewed trials." In three of the studies, participants taking kava extract demonstrated significant decreases in anxiety symptoms measured forward the standardized "Hamilton Anxiety Scale." Like many conventional medical doctors investigating botanical medicine, these authors hedge their bets slightly, noting that none of the studies they examined were "completely flawless" and call for "further and more rigorous investigations." Nonetheless, the authors do acknowledge that the research they examined is conclusive: kava works well in the treatment of anxiety. It is an herb worth taking seriously. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |